908 Devices (MASS) Common Equity (2020 - 2026)
908 Devices' (MASS) quarterly Common Equity came in at $134.2 million in Q1 2026, down 15.84% year-on-year from $159.4 million in Q1 2025, and down 6.63% on a QoQ basis from $143.7 million in Q4 2025.
908 Devices (MASS) Common Equity (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Common Equity data on file, last reported at $134.2 million in Q1 2026.
- On a quarterly basis, Common Equity fell 15.84% year-over-year to $134.2 million in Q1 2026; TTM through Mar 2026 was $134.2 million, a 15.84% decrease from a year earlier, with the FY2025 full-year figure at $143.7 million, up 25.4% from the prior year.
- Common Equity for Q1 2026 stood at $134.2 million, down from $143.7 million in the prior quarter.
- Over the last five years, Common Equity for MASS reached as high as $206.8 million in Q1 2022 and fell as low as $114.6 million in Q4 2024.
- Historically, Common Equity has averaged $162.8 million across 5 years, with a median of $159.4 million in 2025.
- Across the five-year window, Common Equity surged 60.05% in 2022 and slumped 30.76% in 2024, its largest moves.
- Year by year, Common Equity stood at $190.6 million in 2022, then retreated by 13.17% to $165.5 million in 2023, then plunged by 30.76% to $114.6 million in 2024, then gained by 25.4% to $143.7 million in 2025, then retreated by 6.63% to $134.2 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $134.2 million in Q1 2026, $143.7 million in Q4 2025, and $136.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | 908 Devices | 261.78 Mn | 150.04 Mn | 6.88 Mn | 134.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.17 Mn |
| Dec 31, 2025 | 143.70 Mn |
| Sep 30, 2025 | 136.30 Mn |
| Jun 30, 2025 | 148.82 Mn |
| Mar 31, 2025 | 159.42 Mn |
| Dec 31, 2024 | 114.59 Mn |
| Sep 30, 2024 | 131.04 Mn |
| Jun 30, 2024 | 156.36 Mn |
| Mar 31, 2024 | 156.89 Mn |
| Dec 31, 2023 | 165.49 Mn |
| Sep 30, 2023 | 169.93 Mn |
| Jun 30, 2023 | 174.46 Mn |
| Mar 31, 2023 | 180.61 Mn |
| Dec 31, 2022 | 190.60 Mn |
| Sep 30, 2022 | 196.50 Mn |
| Jun 30, 2022 | 201.12 Mn |
| Mar 31, 2022 | 206.80 Mn |
| Dec 31, 2021 | 214.60 Mn |
| Sep 30, 2021 | 122.78 Mn |
| Jun 30, 2021 | 126.67 Mn |